Kelly Lynne Harrison

US Patent:

7454887, Nov 25, 2008

Filed:

Aug 12, 2005

Appl. No.:

11/202893

Inventors:

Kelly Harrison - Brentwood CA, US
David Schneider - Brentwood CA, US

International Classification:

A43C 17/04

US Classification:

54 831

Abstract:

A strapless spur system having a retainer attached to a boot or other footwear, a detachable base with a spring loaded plunger for secure attachment and detachment of the base to the retainer on the footwear. A preferred embodiment includes a mechanism built into the base which releasably engages the spur. The mechanism may be a spring lock which engages a void on the retainer. The spur assembly may have an upward or downward configured spur and the spur assembly may be engaged to the footwear with any of a number of reciprocal mating configurations.

US Patent:

8062657, Nov 22, 2011

Filed:

Oct 18, 2006

Appl. No.:

11/550642

Inventors:

Jeffrey L. Edelman - Newport Beach CA, US
Kelly M. Harrison - Newport Beach CA, US

Assignee:

Allergan, Inc. - Irvine CA

International Classification:

A61F 2/14

US Classification:

424428

Abstract:

Ophthalmically therapeutic materials, such as liquid-containing compositions and polymeric drug delivery systems, include a therapeutic component that includes an Glucocorticoid Derivative which, upon delivery to the posterior segment of a mammalian eye, does not significantly diffuse to the anterior segment of said eye. Methods of making and using the present materials are also described.

US Patent:

20030033789, Feb 20, 2003

Filed:

Aug 14, 2001

Appl. No.:

09/929421

Inventors:

Kelly Harrison - Brentwood CA, US
David Schneider - Brentwood CA, US

International Classification:

A43C017/00

US Classification:

054/083100

Abstract:

A strapless spur system having a base attached to a boot or other footwear, the spur assembly mating with the base on the footwear. A preferred embodiment includes a base that is threaded and built into the boot, and a knurled annular base to assist in mounting the spur to the base or retainer. The spur assembly may also be attached by a mounting plate and have a telescoping spur.

US Patent:

20090044500, Feb 19, 2009

Filed:

Oct 24, 2008

Appl. No.:

12/257819

Inventors:

Kelly Harrison - Brentwood CA, US
David Schneider - Brentwood CA, US

International Classification:

A43C 17/00

US Classification:

54 831

Abstract:

A strapless spur system having a retainer attached to a boot or other footwear, a detachable base with a spring loaded plunger for secure attachment and detachment of the base to the retainer on the footwear. A preferred embodiment includes a mechanism built into the base which releasably engages the spur. The mechanism may be a spring lock which engages a void on the retainer. The spur assembly may have an upward or downward configured spur and the spur assembly may be engaged to the footwear with any of a number of reciprocal mating configurations.

US Patent:

20090082321, Mar 26, 2009

Filed:

Sep 21, 2007

Appl. No.:

11/859627

Inventors:

JEFFREY L. EDELMAN - Irvine CA, US
Kelly M. Harrison - Liverpool NY, US
Patrick M. Hughes - Aliso Viejo CA, US
Lon T. Spada - Walnut CA, US

Assignee:

ALLERGAN, INC. - Irvine CA

International Classification:

A61K 31/57
A61P 27/02

US Classification:

514178

Abstract:

Pharmaceutical composition for intraocular use comprising a glucocorticoid derivative, such as beclomethasone 17,21-diproprionate admixed with a biodegradable polymer such as a poly(lactide-co-glycolide) polymer or a high molecular weight polymeric hyaluronic acid are disclosed.

US Patent:

20110077229, Mar 31, 2011

Filed:

Dec 6, 2010

Appl. No.:

12/960971

Inventors:

Jeffrey L. Edelman - Irvine CA, US
Kelly M. Harrison - Liverpool NY, US
Patrick M. Hughes - Aliso Viejo CA, US
Lon T. Spada - Walnut CA, US

International Classification:

A61K 31/573
A61K 31/56
A61P 27/02

US Classification:

514180, 514179

Abstract:

Pharmaceutical composition for intraocular use comprising a glucocorticoid derivative, such as beclomethasone 17,21-diproprionate admixed with a biodegradable polymer such as a poly(lactide-co-glycolide) polymer or a high molecular weight polymeric hyaluronic acid are disclosed.

US Patent:

20120065178, Mar 15, 2012

Filed:

Nov 17, 2011

Appl. No.:

13/299215

Inventors:

Jeffrey L. Edelman - Irvine CA, US
Kelly M. Harrison - Newport Beach CA, US

International Classification:

A61K 31/56
A61K 31/58
A61P 27/02
A61K 31/573

US Classification:

514172, 514180

Abstract:

Ophthalmically therapeutic materials, such as liquid-containing compositions and polymeric drug delivery systems, include a therapeutic component that includes an Glucocorticoid Derivative which, upon delivery to the posterior segment of a mammalian eye, does not significantly diffuse to the anterior segment of said eye. Methods of making and using the present materials are also described.